XML 52 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED COMPENSATION (Tables)
 12 Months Ended
Jan. 28, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense, Net of Estimated Forfeitures
The following table presents total stock-based compensation expense, net of estimated forfeitures, including expense related to our ESPPs, and related income tax benefit:
in millionsFiscalFiscalFiscal
202320222021
Pre-tax stock-based compensation expense$382 $367 $403 
Income tax benefit(79)(73)(86)
After-tax stock-based compensation expense$303 $294 $317 
Schedule of Option Valuation Assumptions
The following table presents the per share weighted average fair value of stock options granted and the assumptions used in determining fair value at the date of grant using the Black-Scholes option-pricing model: 
 FiscalFiscalFiscal
 202320222021
Per share weighted average fair value$66.01 $70.21 $57.71 
Risk-free interest rate3.6 %2.5 %1.0 %
Assumed volatility26.7 %27.0 %26.5 %
Assumed dividend yield2.8 %2.4 %2.2 %
Assumed lives of options6 years6 years6 years
Schedule of Option Activity by Number of Shares and Weighted Average Exercise Price
The following table presents a summary of stock option activity by number of shares and weighted average exercise price during fiscal 2023:
shares in thousandsNumber of
Shares		Weighted Average
Exercise Price
Outstanding at beginning of year3,626 $167.66 
Granted235 283.85 
Exercised(743)106.96 
Forfeited(33)275.93 
Outstanding at end of year3,085 189.97 
Intrinsic Value of Stock Options Exercised
The following table presents the total intrinsic value of stock options exercised:
in millionsFiscalFiscalFiscal
202320222021
Total intrinsic value of stock options exercised$152 $61 $237 
Schedule of Options Outstanding and Exercisable
The following table presents details regarding outstanding and exercisable stock options at January 28, 2024:
shares in thousands, dollars in millions, except for per share amountsNumber of
Shares		Intrinsic
Value		Weighted Average
Remaining Life		Weighted Average
Exercise Price
Outstanding3,085 $510 4.6 years$189.97 
Exercisable2,102 424 3.2 years153.57 
Schedule of Restricted Stock, Performance Shares, and Restricted Stock Unit Activity
The following table presents a summary of restricted stock, performance shares, and restricted stock unit activity during fiscal 2023:
shares in thousandsNumber of
Shares		Weighted Average
Grant Date Fair Value
Nonvested at beginning of year3,359 $261.66 
Granted1,692 273.63 
Vested(1,429)231.72 
Forfeited(236)277.20 
Nonvested at end of year3,386 279.19 
Schedule of total fair value of restricted stock, performance shares, and restricted stock units that vested
The following table presents the total fair value of restricted stock, performance shares, and restricted stock units vested:
in millionsFiscalFiscalFiscal
202320222021
Total fair value vested$412 $479 $405 
Schedule of deferred shares granted
The following table presents deferred shares granted to non-employee directors:
FiscalFiscalFiscal
202320222021
Deferred shares granted to non-employee directors19,000 19,000 15,000